YON AMIOTROFIK SKLEROZNING ERTA BOSQICHLARIDA RTMS QOʻLLASHNING KLINIK SAMARADORLIGINI BAHOLASH

Authors

  • Abdukadirova D.T. t.f.n. dotsent
  • Xoshimjonov B. Magistratura talabasi Andijon davlat tibbiyot instituti Nevrologiya kafedrasi

Keywords:

Yon amiotrofik skleroz, kortikal giperqoʻzgʻaluvchanlik, repetitiv transkranial magnit stimulyatsiya, ALSFRS-R, motoneyron degeneratsiyasi, neyromodulyatsiya

Abstract

Yon amiotrofik skleroz (YoASK) — yuqori va pastki motoneyronlarning progressiv degeneratsiyasi bilan kechuvchi, ogʻir nogironlik va oʻlimga olib keluvchi neyrodegenerativ kasallikdir. Kasallik patogenezida kortikal giperqo’zgaluvchanlik erta neyrofiziologik biomarker sifatida muhim oʻrin tutadi hamda motoneyron shikastlanishining boshlangʻich bosqichlarini aks ettirishi mumkin. Repetitiv transkranial magnit stimulyatsiya (rTMS) bosh miya poʻstlogʻining qoʻzgʻaluvchanligini modulyatsiya qiluvchi, invaziv boʻlmagan neyromodulyatsion usul boʻlib, u kortikal plastiklik mexanizmlariga ta’sir koʻrsatish orqali kasallik progressiyasini sekinlashtirish ehtimolini beradi. Mazkur maqolada YoASKning erta bosqichlarida rTMS qoʻllashning klinik samaradorligi baholanadi. Asosiy baholash mezoni sifatida ALS Functional Rating Scale – Revised (ALSFRS-R) shkalasi koʻrsatkichlari hamda motor funksiyalarning dinamik oʻzgarishlari tahlil qilinadi. Tadqiqot natijalari rTMSning kortikal gipereksitabilitetni kamaytirish orqali funksional koʻrsatkichlarga potensial ijobiy ta’sirini koʻrsatishi mumkin.

References

Mills K.R., Nithi K.A. Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis // Muscle & Nerve. — 1997. — Vol. 20, No. 9. — P. 1137–1141.

Zanette G., Tamburin S., Manganotti P., Refatti N., Forgione A., Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis // Clinical Neurophysiology. — 2002. — Vol. 113, No. 11. — P. 1688–1697.

Vucic S., Ziemann U., Eisen A., Hallett M., Kiernan M.C. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights // Journal of Neurology, Neurosurgery & Psychiatry. — 2013. — Vol. 84, No. 10. — P. 1161–1170.

Shaw P.J., Ince P.G. Glutamate, excitotoxicity and amyotrophic lateral sclerosis // Journal of Neurology. — 1997. — Vol. 244, Suppl. 2. — P. S3–S14.

King A.E., Woodhouse A., Kirkcaldie M.T.K., Vickers J.C. Excitotoxicity in ALS: Overstimulation, or overreaction? // Experimental Neurology. — 2016. — Vol. 275, Pt. 1. — P. 162–171.

Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function // Journal of the Neurological Sciences. — 1999. — Vol. 169, No. 1–2. — P. 13–21.

Vucic S., Pavey N., Haidar M., Turner B.J., Kiernan M.C. Cortical hyperexcitability: diagnostic and pathogenic biomarker of ALS // Neuroscience Letters. — 2021. — Vol. 759. — Art. 136039.

Fang J., Zhou M., Yang M., Zhu C., He L. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease // Cochrane Database of Systematic Reviews. — 2013. — Issue 5. — Art. CD008554.

Акбарова С. Ш., Абдукадирова Д.Т.,Рахимбаева Г. С. Atypical forms of ALS: review andobservation from practice. British Medical Journal. voleum 2. No 1.1, 11-15. January 2022 https://ejournals.id/index.php/bmj/article/view/387/364

Abdukadirova D.T., Abdukadirov U.T., Xoshimjonov B.Sh. DIAGNOSTIC CRITERIA FOR AMYOTROPHIC LATERAL SCLEROSIS.JOURNAL OF MULTIDISCIPLINARY SCIENCES AND INNOVATIONS.volume 4, issue 2, 2025.https://ijmri.de/index.php/jmsi

Downloads

Published

2026-10-13

How to Cite

Abdukadirova D.T., & Xoshimjonov B. (2026). YON AMIOTROFIK SKLEROZNING ERTA BOSQICHLARIDA RTMS QOʻLLASHNING KLINIK SAMARADORLIGINI BAHOLASH. IQRO , 24(01), 859–865. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/9535